Continuous glucose monitors and insulin pumps
Pharmac funds continuous glucose monitors and insulin pumps for people with type 1 diabetes and some other types of diabetes.
On this page
URGENT MEDICAL DEVICE PRODUCT CORRECTION
The Dexcom company, NZMS Diabetes, have told us about a problem with the Dexcom G7 App, versions 2.9 - 2.11.2, and the Dexcom G7 iOS App, version 2.12.
What’s the issue?
- Critical alerts may not vibrate.
- Alerts about low storage space or device errors may not sound or vibrate for up to 25 minutes.
- You could miss or delay noticing low or high glucose levels, which could put your health at risk.
What you need to do
- Open the App Store or Google Play Store.
- Search for Dexcom G7.
- Install the latest version of the app.
- Once the update is installed, use the acknowledgement link provided to confirm you have completed the update.
Contact
NZMS Diabetes apologizes for the inconvenience. If you need help, contact their technical support number on 0508 634 103.
The latest news for CGMs
Dexcom G7 Sensor Product Alert
MyLife YpsoPump Orbit Soft infusion sets now funded
From 1 August 2026, Pharmac funded the Orbit Soft infusion sets that offer a flexible insertion. Four size options are funded.
Schedule listing for MyLife Orbit Soft infusion sets(external link)
Tandem pump users with Basal-IQ technology
A new software update is available, Control-IQ 7.10.4 can now support diabetes management through pregnancy. Dexcom has resource in place to support your transition to the latest version of Control-IQ.
Report faulty CGMs
Pharmac limits the number of CGMs people can access each year. If you have a faulty CGM, you need it replaced by the supplier. If you don't, you will likely run out of funded CGMs.
Who to contact
Report faulty Dexcoms(external link) or 0508 634 103
Support for FreeStyle Libre models(external link)
The suppliers will provide you a replacement free of charge.
When does my CGM allocation reset?
Each type of CGM has a specific number of devices funded in a 12-month period. Your allocation resets to zero on the anniversary of when your funding was approved, the Special Authority application.
Your pharmacist can advise you when your allocation resets. This date will be different for everyone.
Clinical need for more CGMs
There can be a clinical reason that someone needs more CGMs than Pharmac funds by default. If you think this may describe you, talk to doctor or diabetes team.
They may be able to apply to Pharmac for an increased allocation of funded CGMs. This would be through Pharmac's Special Authority waiver process.
Applying for a Special Authority waiver
CGMs for type 2 diabetes
Currently, CGMs are not funded for people with type 2 diabetes. We have received three applications to consider funding CGMs for more people.
You can read each application and follow its progress on our Application Tracker
Continuous Glucose Monitor funding applications | Application Tracker(external link)
What is funded for who?
Everyone with type 1 diabetes and some other types of diabetes can access these stand-alone CGMs:
- Dexcom One+
- Freestyle Libre 2 Plus
People with funded access to insulin pumps can access:
- Dexcom G6 (until early 2027)
- Dexcom G7
- Freestyle Libre 3 Plus
Funded access to insulin pumps is for people who have been evaluated as likely to benefit from an automated insulin delivery system by a diabetes multidisciplinary team.
Two insulin pumps are funded:
- YpsoPump
- Tandem Pump
Talk to your diabetes team about what options may be right for you.
MiniMed insulin pump users have until 1 October 2026 to move to a new pump
Who to contact
If you have questions about the specifics of any CGMs or insulin pumps, check the suppliers' websites
If you have a question about funding, email enquiry@pharmac.govt.nz